IBM Watson Health Announces the IBM FHIR® Server to Enhance Health Data Interoperability
The IBM FHIR® Server is an open source Java implementation of the HL7 FHIR® R4 specification that has passed the AEGIS Touchstone “basic” test suite for FHIR R4 with 100 percent conformance.
Examining Health Disparities in Precision Medicine
There should be diversity in voices and experience that come to the table to promote fairness and minimize bias for the future of precision medicine and healthcare.
Intelligent Analytics Help Enable Better Oncology Performance
Guest bloggers from analyst firm IDC share their perspective on how technology can help address some of the challenges within oncology today.
How to Help Manage Rapid Growth in the Emergency Department
Dr. Dave Holson, director of the ED at NYC Health + Hospitals/Queens shared his perspective on the value of continuous improvement in a rapidly expanding ED.
Clinical Trial Matching: The Frustration of Matching Patients to Cancer Research Begins with Data Issues — and Can End with Artificial Intelligence
If you work in oncology or cancer clinical trial coordination in the US, you already know the numbers don’t always work in your or your patients’ favor.
Forrester Names IBM a Leader in Enterprise Health Cloud
Healthcare organizations face challenges as they move their workloads to cloud and incorporate data into their decision-making, including data integration, patient matching and risk stratification. In a recent evaluation, IBM has been named by Forrester as a Leader in “The Forrester Wave™: Enterprise Health Clouds, Q3 2019.”
The Rise of Consumer Experience in Healthcare
Responding to healthcare consumer trends may seem daunting, but there are some fundamental places to begin.
Convergence of government, payers and providers to solve the opioid epidemic
If you had unlimited funding and authority, what would you do to fix the opioid epidemic?
Research suggests link between hospital performance and telehealth adoption
This data is part of the IBM Watson Health 100 Top Hospitals® 2019 study identifying the U.S. hospitals with the highest balanced performance.
Three ways to run a more efficient drug trial
Focusing on drug trial efficiency can go a long way towards cutting costs and reducing the impact of trial failures and delays on the bottom line.
Data: friend, foe or both? How life sciences leaders can benefit from data proliferation
Companies could benefit from using the wealth of intelligence to optimize the product development and commercialization process, if they can quickly access information when and where it’s needed most.
Maximize your drug’s potential with data
From the earliest stages of discovery through treatment delivery, analytics and insights have the potential to inform and enhance every stage of the drug development and commercialization process.